Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanfranco Fattorini

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Annali Dell'Istituto Superiore Di Sanita|January 23, 2008
Extensively drug-resistant (XDR) tuberculosis: an old and new threatLanfranco Fattorini, Giovanni Battista Migliori, Antonio Cassone
Mediterranean Journal of Hematology and Infectious Diseases|December 24, 2013
Targeting dormant bacilli to fight tuberculosisLanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, et al.
Annali Dell'Istituto Superiore Di Sanita|September 22, 2020
Bacterial coinfections in COVID-19: an underestimated adversaryLanfranco Fattorini, Roberta Creti, Carla Palma, et al.
Microorganisms|June 28, 2023
Eradication of Drug-Tolerant <i>Mycobacterium tuberculosis</i> 2022: Where We StandAlessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Annali Dell'Istituto Superiore Di Sanita|June 20, 2023
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020Federico Giannoni, Alessio Lanni, Angelo Iacobino, et al.
The Journal of Antibiotics|May 26, 2018
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditionsAngelo Iacobino, Federico Giannoni, Lanfranco Fattorini, et al.
Frontiers in Microbiology|August 18, 2025
Activity of combinations of bactericidal and bacteriostatic compounds in <i>Mycobacterium abscessus</i>-infected mice: an overviewAlessio Lanni, Elisabetta Iona, Lanfranco Fattorini, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosisGiovanni Piccaro, Donatella Pietraforte, Federico Giannoni, et al.
Microorganisms|January 30, 2021
Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent MannerAngelo Iacobino, Giovanni Piccaro, Manuela Pardini, et al.
International Journal of Mycobacteriology|August 5, 2017
Fighting tuberculosis by drugs targeting nonreplicating <i>Mycobacterium tuberculosis</i> bacilliAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Annali Dell'Istituto Superiore Di Sanita|January 23, 2008
Extensively drug-resistant (XDR) tuberculosis: an old and new threatLanfranco Fattorini, Giovanni Battista Migliori, Antonio Cassone
Mediterranean Journal of Hematology and Infectious Diseases|December 24, 2013
Targeting dormant bacilli to fight tuberculosisLanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, et al.
Annali Dell'Istituto Superiore Di Sanita|September 22, 2020
Bacterial coinfections in COVID-19: an underestimated adversaryLanfranco Fattorini, Roberta Creti, Carla Palma, et al.
Microorganisms|June 28, 2023
Eradication of Drug-Tolerant <i>Mycobacterium tuberculosis</i> 2022: Where We StandAlessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Annali Dell'Istituto Superiore Di Sanita|June 20, 2023
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020Federico Giannoni, Alessio Lanni, Angelo Iacobino, et al.
The Journal of Antibiotics|May 26, 2018
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditionsAngelo Iacobino, Federico Giannoni, Lanfranco Fattorini, et al.
Frontiers in Microbiology|August 18, 2025
Activity of combinations of bactericidal and bacteriostatic compounds in <i>Mycobacterium abscessus</i>-infected mice: an overviewAlessio Lanni, Elisabetta Iona, Lanfranco Fattorini, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosisGiovanni Piccaro, Donatella Pietraforte, Federico Giannoni, et al.
Microorganisms|January 30, 2021
Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent MannerAngelo Iacobino, Giovanni Piccaro, Manuela Pardini, et al.
International Journal of Mycobacteriology|August 5, 2017
Fighting tuberculosis by drugs targeting nonreplicating <i>Mycobacterium tuberculosis</i> bacilliAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Pageof 7